Biofrontera Inc. Increase (Decrease) in Inventories
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Inventories of -$386.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$79.00K.
- Biofrontera Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$307.00K.
- Biofrontera Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $872.00K, a 493.20% increase year-over-year.
- Biofrontera Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $301.00K, a 88.34% decline year-over-year.
- Biofrontera Inc. increase (decrease) in inventories for fiscal 2025 was -$1.45M.
- Biofrontera Inc. increase (decrease) in inventories for fiscal 2024 was -$4.23M, a 212.88% decline from fiscal 2023.
- Biofrontera Inc. increase (decrease) in inventories for fiscal 2023 was $3.75M, a 33.45% increase from fiscal 2022.
- Biofrontera Inc. increase (decrease) in inventories for fiscal 2022 was $2.81M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$386.00K 10-Q · filed 2026-08-13 | $486.00K derived: sum of 3 quarters · filed 2026-08-13 | $787.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$307.00K 10-Q · filed 2026-05-14 | $565.00K derived: sum of 2 quarters · filed 2026-05-14 | $866.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.63M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $872.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.17M derived: sum of 2 quarters · filed 2026-03-19 | -$1.33M derived: sum of 3 quarters · filed 2026-08-13 | -$1.45M 10-K · filed 2026-03-19 |
| 2025-09-30 | $301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.20M derived: sum of 2 quarters · filed 2026-08-13 | -$2.32M 10-Q · filed 2025-11-12 | -$2.17M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$2.62M 10-Q · filed 2026-08-13 | -$2.47M derived: sum of 3 quarters · filed 2026-08-13 | $110.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$119.00K 10-Q · filed 2026-05-14 | $28.00K derived: sum of 2 quarters · filed 2026-05-14 | $2.61M derived: sum of 3 quarters · filed 2026-05-14 | -$349.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $2.73M derived: sum of 2 quarters · filed 2026-03-19 | -$230.00K derived: sum of 3 quarters · filed 2026-03-19 | -$4.23M 10-K · filed 2026-03-19 |
| 2024-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$377.00K derived: sum of 2 quarters · filed 2025-11-12 | -$4.38M 10-Q · filed 2025-11-12 | -$9.53M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$6.96M 10-Q · filed 2025-08-13 | -$12.11M derived: sum of 3 quarters · filed 2025-08-13 | -$10.83M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$4.00M 10-Q · filed 2025-05-15 | -$9.15M derived: sum of 2 quarters · filed 2025-05-15 | -$7.87M derived: sum of 3 quarters · filed 2025-05-15 | $246.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.87M derived: sum of 2 quarters · filed 2025-03-20 | $4.25M derived: sum of 3 quarters · filed 2025-03-20 | $3.75M 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $9.40M derived: sum of 2 quarters · filed 2024-11-14 | $8.90M 10-Q · filed 2024-11-14 | $3.98M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.62M 10-Q · filed 2024-08-14 | $2.70M derived: sum of 3 quarters · filed 2024-08-14 | $5.98M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$499.00K 10-Q · filed 2024-05-15 | -$5.42M derived: sum of 2 quarters · filed 2024-05-15 | -$2.14M derived: sum of 3 quarters · filed 2024-05-15 | $1.90M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$1.64M derived: sum of 2 quarters · filed 2024-03-15 | $2.40M derived: sum of 3 quarters · filed 2024-03-15 | $2.81M 10-K · filed 2024-03-15 |
| 2022-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $7.31M derived: sum of 2 quarters · filed 2023-11-09 | $7.73M 10-Q · filed 2023-11-09 | $6.75M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $4.45M 10-Q · filed 2023-08-11 | $3.47M derived: sum of 3 quarters · filed 2023-10-03 | $2.19M derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-03-31 | $414.00K 10-Q · filed 2023-05-12 | -$565.00K derived: sum of 2 quarters · filed 2023-10-03 | -$1.85M derived: sum of 3 quarters · filed 2023-10-03 | -$3.54M derived: sum of 4 quarters · filed 2023-10-03 |
| 2021-12-31 | -$979.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | -$2.26M derived: sum of 2 quarters · filed 2023-10-03 | -$3.96M derived: sum of 3 quarters · filed 2023-10-03 | -$2.59M 8-K · filed 2023-10-03 |
| 2021-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.98M derived: sum of 2 quarters · filed 2022-11-14 | -$1.61M 10-Q · filed 2022-11-14 | -$467.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$330.00K 10-Q · filed 2022-08-12 | $816.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $1.37M 10-Q · filed 2022-05-13 | $2.51M derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $273.00K 10-K · filed 2022-04-11 | ||
| 2020-09-30 | -$873.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |